BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaushal N, Tiruchinapally G, Durmaz YY, Bao L, Gilani R, Merajver SD, ElSayed MEH. Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on "smart" particles. J Control Release 2018;289:79-93. [PMID: 30149048 DOI: 10.1016/j.jconrel.2018.07.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Deng Q, Zhuang T, Lu Y, Liu T, Zhao W, Lin B, Luo Y, Zhang X. 3D bioprinted breast tumor model for structure–activity relationship study. Bio-des Manuf 2020;3:361-72. [DOI: 10.1007/s42242-020-00085-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhang Q, Wang J, Liu D, Zhu W, Guan S, Fan L, Cai D. Targeted delivery of honokiol by zein/hyaluronic acid core-shell nanoparticles to suppress breast cancer growth and metastasis. Carbohydr Polym 2020;240:116325. [PMID: 32475585 DOI: 10.1016/j.carbpol.2020.116325] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
3 Xu W, Li G, Long H, Fu G, Pu L. Glutathione responsive poly(HPMA) conjugate nanoparticles for efficient 6-MP delivery. New J Chem 2019;43:12215-20. [DOI: 10.1039/c9nj02582k] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Zhang N, Yang Y, Wang Z, Yang J, Chu X, Liu J, Zhao Y. Polypeptide-engineered DNA tetrahedrons for targeting treatment of colorectal cancer via apoptosis and autophagy. Journal of Controlled Release 2019;309:48-58. [DOI: 10.1016/j.jconrel.2019.07.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Thomas P, Pranatharthi A, Ross C, Srivastava S. RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target. J Exp Clin Cancer Res. 2019;38:328. [PMID: 31340863 DOI: 10.1186/s13046-019-1327-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]